Trial Profile
A Multicentre, Open Label, Uncontrolled Study of the Tolerance, Acceptability and Contraceptive Efficacy of Mirena 52 mg®, an Intra-uterine Levonorgestrel Device, During the First Year After Insertion Post-partum
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Jan 2015
Price :
$35
*
At a glance
- Drugs Levonorgestrel (Primary)
- Indications Pregnancy
- Focus Adverse reactions
- Sponsors Bayer
- 11 Jul 2008 New trial record.